Vector Shared Resource
Vector Shared Resource
批准号:
7944613
负责人:
NORIYUKI KASAHARA
金额:
$11.59万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-04-02 至 2013-11-30
关键词:
Adenovirus VectorAnimal ExperimentsApplications GrantsAreaCancer CenterCancer Center Support GrantCell Culture TechniquesCellular biologyCharacteristicsConsultationsCustomDevelopmentDiseaseDominant-Negative MutationEpitopesGene DeliveryGene Expression RegulationGene TransferGenesGeneticGenitourinary systemHematopoietic NeoplasmsIn VitroIndividualJonsson Comprehensive Cancer Center of University of California Los AngelesLaboratoriesLibrariesMalignant - descriptorMalignant NeoplasmsMammalian CellMethodologyMolecular Epidemiology of CancerOrganogenesisPathogenesisPreparationProductionRecording of previous eventsReportingResearchResearch ActivityResearch PersonnelResource SharingResourcesServicesSignal TransductionSourceTechniquesTechnologyTherapeuticThoracic OncologyTransgenesTranslational ResearchViral VectorWomanWorkanticancer researchcancer cellcellular engineeringcostdesign and constructionexperiencegene therapyin vivointerestmeetingsmembermolecular imagingmutantnew therapeutic targetoncologyprogramsresearch studytumor immunologyvector
中文摘要
矢量共享资源(VSR)。基于病毒的高效细胞工程技术进展
英文摘要
The Vector Shared Resource (VSR). Advances in techniques for efficient cellular engineering using virusbased
gene delivery vehicles ("vectors") have made it feasible to utilize gene transfer as a methodology for
elucidating functions of specific genes, by examining consequences of their over-expression or inhibition.
The Vector Shared Resource is a new Shared Resource, established to meet the increasing demand both
for routine construction and production of viral vectors and for assistance in developing new vectors, both for
cell culture and in vivo animal experiments. The objective of the Vector Shared Resource is to promote and
Facilitate basic and translational research by providing JCCC investigators with access to vector technologies
that enable efficient gene transfer to mammalian cells, both in culture and in vivo. Our services include: (1)
provision, at minimal cost, of various pre-made retroviral, lentiviral and adenoviral vector stocks expressing
standard marker genes to utilize in preliminary experiments, as well as a library of available vectors
expressing various mammalian genes and corresponding inhibitory sequences; (2) construction and
production of custom viral vectors that contain a specific sequence(s) of interest (including wild type and
mutant cDNAs with or without epitope tags, dominant-negative expression constructs, antisense mRNAs,
siRNAs, etc.) for individual researchers; and (3) provision of educational and advisory resources for
researchers with limited experience in viral vector technologies, but who wish to utilize such technologies for
efficient functional expression of genetic sequences of interest in vitro and/or in vivo. As the use of viral
vector technology requires specialized expertise and resources often not found in an individual investigator's
laboratory, offering easy access to these technologies, consolidated in the form of a Shared Resource, can
significantly facilitate and expand the scope of JCCC research activities. Furthermore, our services are
more cost-effective than utilizing the limited commercial sources offering such technologies. Further value is
added by customized technical support available from accessible and knowledgeable Shared Resource staff
who can work closely with investigators to troubleshoot and optimize gene transfer experiments, assist with
institutional regulatory compliance documents and grant proposal submissions and who are actively
engaged in development and application of new vector technologies. Initiated in 2003, the Vector Shared
Resource has been used by members of the Signal Transduction and Therapeutics, Women's Cancer,
Hematopoietic Malignancies, Gene Regulation, Cancer Cell Biology, Tumor Immunology, Thoracic
Oncology, Genitourinary Oncology, Molecular Epidemiology and Cancer Molecular Imaging Program Areas
for consultation, vector construction, small and large scale preparation of vector stocks and additional
services. (Please also see Section 6.2.3 on Shared Resources in the History, Description, Essential
Characteristics).
25 Cancer Center members representing 10 Cancer Center Program Areas utilized the services of the
Vector Shared Resource during the reporting period. This is a new shared resource.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
GALV-Based Retroviral Replicating Vectors for Glioma Gene Therapy
-
批准号:10443010
-
项目类别:
-
资助金额:$40.37万
-
财政年份:2019
-
负责人:NORIYUKI KASAHARA
-
依托单位:
Retroviral Replicating Vector-mediated Gene Therapy for Ovarian Cancer
-
批准号:9754592
-
项目类别:
-
资助金额:$51.15万
-
财政年份:2017
-
负责人:NORIYUKI KASAHARA
-
依托单位:
Retroviral Replicating Vector-mediated Gene Therapy for Ovarian Cancer
-
批准号:9384558
-
项目类别:
-
资助金额:$50.4万
-
财政年份:2017
-
负责人:NORIYUKI KASAHARA
-
依托单位:
Retroviral Replicating Vector-mediated Gene Therapy for Ovarian Cancer
-
批准号:10017020
-
项目类别:
-
资助金额:$53.03万
-
财政年份:2017
-
负责人:NORIYUKI KASAHARA
-
依托单位:
Translational Development of Replication-Competent Retrovirus Vectors
-
批准号:8548414
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:NORIYUKI KASAHARA
-
依托单位:
Translational Development of Replication-Competent Retrovirus Vectors
-
批准号:8077255
-
项目类别:
-
资助金额:$91.4万
-
财政年份:2010
-
负责人:NORIYUKI KASAHARA
-
依托单位:
Translational Development of Replication-Competent Retrovirus Vectors
-
批准号:8322132
-
项目类别:
-
资助金额:$93.92万
-
财政年份:2010
-
负责人:NORIYUKI KASAHARA
-
依托单位:
Translational Development of Replication-Competent Retrovirus Vectors
-
批准号:7826184
-
项目类别:
-
资助金额:$102.62万
-
财政年份:2010
-
负责人:NORIYUKI KASAHARA
-
依托单位:
MOLECULAR VECTORS AND PEPTIDOMICS CORE
-
批准号:7767527
-
项目类别:
-
资助金额:$12.12万
-
财政年份:2009
-
负责人:NORIYUKI KASAHARA
-
依托单位:
Cellular Transduction with Replication-Competent Retrovirus Vectors
-
批准号:7554139
-
项目类别:
-
资助金额:$48.19万
-
财政年份:2007
-
负责人:NORIYUKI KASAHARA
-
依托单位:
Cellular Transduction with Replication-Competent Retrovirus Vectors
-
批准号:7746420
-
项目类别:
-
资助金额:$43.45万
-
财政年份:2007
-
负责人:NORIYUKI KASAHARA
-
依托单位:
Cellular Transduction with Replication-Competent Retrovirus Vectors
-
批准号:8017370
-
项目类别:
-
资助金额:$47.68万
-
财政年份:2007
-
负责人:NORIYUKI KASAHARA
-
依托单位:
Cellular Transduction with Replication-Competent Retrovirus Vectors
-
批准号:7383097
-
项目类别:
-
资助金额:$46.79万
-
财政年份:2007
-
负责人:NORIYUKI KASAHARA
-
依托单位:
Cellular Transduction with Replication-Competent Retrovirus Vectors
-
批准号:7261648
-
项目类别:
-
资助金额:$48.01万
-
财政年份:2007
-
负责人:NORIYUKI KASAHARA
-
依托单位:
CORE--MOLECULAR BIOLOGY AND VECTORS
-
批准号:7415065
-
项目类别:
-
资助金额:$5.73万
-
财政年份:2006
-
负责人:NORIYUKI KASAHARA
-
依托单位:
Combining Virotherapy and Immunotherapy for Cancer
-
批准号:7005665
-
项目类别:
-
资助金额:$30.93万
-
财政年份:2004
-
负责人:NORIYUKI KASAHARA
-
依托单位:
Combining Virotherapy and Immunotherapy for Cancer
-
批准号:7177498
-
项目类别:
-
资助金额:$30.03万
-
财政年份:2004
-
负责人:NORIYUKI KASAHARA
-
依托单位:
Combining Virotherapy and Immunotherapy for Cancer
-
批准号:6846599
-
项目类别:
-
资助金额:$31.59万
-
财政年份:2004
-
负责人:NORIYUKI KASAHARA
-
依托单位:
CORE--MOLECULAR BIOLOGY AND VECTORS
-
批准号:6863977
-
项目类别:
-
资助金额:$5.9万
-
财政年份:2004
-
负责人:NORIYUKI KASAHARA
-
依托单位:
Combining Virotherapy and Immunotherapy for Cancer
-
批准号:7345428
-
项目类别:
-
资助金额:$30.03万
-
财政年份:2004
-
负责人:NORIYUKI KASAHARA
-
依托单位:
海外基金